Company
Last deal
$8.7M
Local Amount - CHF 10.3M
Amount
Series A
Stage
21.08.2024
Date
3
all rounds
$27.9M
Total amount
General
About Company
Vandria is developing mitophagy inducers to rejuvenate cells and treat age-related and chronic diseases.
Industry
Sector :
Subsector :
Keywords :
founded date
2021
Number of employees
Company Type
For Profit
Last funding type
Series A
IPO status
Private